Clinical trials investigating venetoclax combinations for AML

Andrew Wei, MBBS, PhD, FRACP, FRCPA, from Monash University, Melbourne, Australia, discusses the early trials that are currently underway to evaluate the efficacy of the BH3 mimetic drug, venetoclax, ... Author: VJHemOnc Added: 06/12/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts